{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:03:23Z","timestamp":1780988603833,"version":"3.54.1"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Generalized pustular psoriasis (GPP) is a severe disease. Treatment options for refractory cases with multiple comorbidities remain limited. This report describes a 72-year-old female patient with a 10-year history of plaque psoriasis. The patient experienced recurrent episodes of GPP over the past year, complicated by type 2 diabetes mellitus, hyperlipidemia, hypertension, stage 3 chronic kidney disease (CKD), and pulmonary interstitial fibrosis. Multiple prior therapies had failed, and several conventional medications were contraindicated due to comorbidities. Additionally, the patient refused further treatment with pesolimab. Oral tacrolimus combined with apremilast was administered, resulting in resolution of skin lesions and improvement in renal function.To our knowledge, this is among the first reported cases of successful treatment for recurrent acute GPP, especially refractory acute GPP, using oral tacrolimus in combination with apremilast. The observed therapeutic response suggests potential shared immunological pathways between acute GPP and CKD, which may be influenced by this combination therapy, contributing to improvements in both skin manifestations and renal function. This case provides a valuable reference for optimizing treatment regimens and investigating mechanisms in refractory GPP. Further studies are required to enhance therapeutic efficacy and minimize adverse effects.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1801541","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:13:39Z","timestamp":1780985619000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Breaking the barrier: oral tacrolimus plus apremilast rescues acute generalized pustular psoriasis with severe comorbidities\u2014a case report"],"prefix":"10.3389","volume":"17","author":[{"given":"Lei","family":"Tang","sequence":"first","affiliation":[{"name":"Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]},{"name":"Department of Dermatology and Cosmetology, Chongqing Traditional Chinese Medicine Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiman","family":"He","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyun","family":"Qiao","sequence":"additional","affiliation":[{"name":"Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Cosmetology, Chongqing Traditional Chinese Medicine Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingsheng","family":"Hao","sequence":"additional","affiliation":[{"name":"Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2025.01.046","article-title":"Il-36-driven pustulosis: Transcriptomic signatures match between generalized pustular psoriasis (GPP) and acute generalized exanthematous pustulosis (AGEP)","volume":"155","author":"Benezeder","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.08.056","article-title":"Il-1 and il-36 are dominant cytokines in generalized pustular psoriasis","volume":"140","author":"Johnston","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00654-z","article-title":"Clinical course and characteristics of generalized pustular psoriasis","volume":"23","author":"Choon","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/24755303251344155","article-title":"All-cause mortality is higher in generalized pustular psoriasis (GPP) than plaque psoriasis and the general population: A US-based claims analysis","author":"Gottlieb","year":"2025","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11040740","article-title":"Characteristics of patients experiencing a flare of generalized pustular psoriasis: A multicenter observational study","volume":"11","author":"Bellinato","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1951192","article-title":"Characteristics of hospitalizations and emergency department visits due to generalized pustular psoriasis in the United States","volume":"37","author":"Hanna","year":"2021","journal-title":"Curr Med Res Opin"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10090","article-title":"A case report of generalized pustular psoriasis associated with IgA nephropathy","volume":"12","author":"Klimko","year":"2020","journal-title":"Cureus"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-025-01535-7","article-title":"Considerations for treating generalized pustular psoriasis (GPP): A narrative review","volume":"15","author":"Lynde","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.12.043","article-title":"Effect of biologic drugs on renal function in psoriasis patients with chronic kidney disease","volume":"82","author":"Maghfour","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.22401","article-title":"Nuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus","volume":"83","author":"Maguire","year":"2013","journal-title":"Cytom A"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1354578","article-title":"Case report: Successful treatment of acute generalized pustular psoriasis with multiple comorbidities with oral tacrolimus","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2016.1206886","article-title":"Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis","volume":"12","author":"Bianchi","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2174\/0127722708351802250717104057","article-title":"Apremilast in psoriasis: Current landscape and perspectives","author":"Kumar","year":"2025","journal-title":"Recent Adv Inflammation Allergy Drug Discov"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1455134","article-title":"Serum il-23 levels reflect a myeloid inflammatory signature and predict the response to apremilast in patients with psoriatic arthritis","volume":"15","author":"De Santis","year":"2024","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002262","article-title":"Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs","volume":"7","author":"Subbian","year":"2011","journal-title":"PloS Pathog"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1668675","article-title":"Combination therapy with spesolimab and apremilast for refractory generalized pustular psoriasis: a case report","volume":"12","author":"Li","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.88108","article-title":"Generalized pustular psoriasis as a systemic inflammatory disease: Experience with 38 Japanese cases over 15 years at a single institution","volume":"17","author":"Kikuchi","year":"2025","journal-title":"Cureus"},{"key":"B18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.kint.2017.09.017","article-title":"Knockout of the interleukin-36 receptor protects against renal ischemia-reperfusion injury by reduction of proinflammatory cytokines","volume":"93","author":"Nishikawa","year":"2018","journal-title":"Kidney Int"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1801541\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:13:46Z","timestamp":1780985626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1801541\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":18,"alternative-id":["10.3389\/fimmu.2026.1801541"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1801541","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"article-number":"1801541"}}